In other words, the price has increased by $0.00 from its previous closing price. On the day, 8833275 shares were traded. MDLZ reached its highest trading level at $61.05 during the session, while it also had its lowest trading level at $59.74.
We take a closer look at MDLZ’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 42.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 55.07. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 0.70. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.65.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cowen on September 14, 2022, initiated with a Outperform rating and assigned the stock a target price of $71.
On March 30, 2022, UBS started tracking the stock assigning a Buy rating and target price of $73.UBS initiated its Buy rating on March 30, 2022, with a $73 target price.
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 11 when Hargrove Robin S. sold 30,500 shares for $65.86 per share. The transaction valued at 2,008,730 led to the insider holds 32,024 shares of the business.
Brusadelli Maurizio sold 26,500 shares of MDLZ for $1,724,885 on Feb 25. The EVP and President AMEA now owns 169,655 shares after completing the transaction at $65.09 per share. On Dec 14, another insider, Gruber Vinzenz P., who serves as the EVP and President, Europe of the company, sold 15,000 shares for $63.30 each. As a result, the insider received 949,500 and left with 107,233 shares of the company.
As of this moment, Mondelez’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.68, and their Forward P/E ratio for the next fiscal year is 18.94. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.71 while its Price-to-Book (P/B) ratio in mrq is 3.00.
Stock Price History:
Over the past 52 weeks, MDLZ has reached a high of $69.47, while it has fallen to a 52-week low of $57.62. The 50-Day Moving Average of the stock is 62.72, while the 200-Day Moving Average is calculated to be 63.71.
According to the various share statistics, MDLZ traded on average about 6.42M shares per day over the past 3-months and 7.39M shares per day over the past 10 days. A total of 1.38B shares are outstanding, with a floating share count of 1.37B. Insiders hold about 0.16% of the company’s shares, while institutions hold 80.00% stake in the company. Shares short for MDLZ as of Jul 14, 2022 were 12.05M with a Short Ratio of 2.17, compared to 16.24M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.87% and a Short% of Float of 0.87%.
Dividends & Splits
The forward annual dividend rate for MDLZ is 1.54, which was 1.23 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 2.06%, it implies a Forward Annual Dividend Yield of 2.40%. The stock’s 5-year Average Dividend Yield is 2.06.
The company has 18 analysts who recommend its stock at the moment. On average, analysts expect EPS of $0.69 for the current quarter, with a high estimate of $0.76 and a low estimate of $0.61, while EPS last year was $0.7. The consensus estimate for the next quarter is $0.71, with high estimates of $0.76 and low estimates of $0.67.
Analysts are recommending an EPS of between $3.01 and $2.86 for the fiscal current year, implying an average EPS of $2.91. EPS for the following year is $3.13, with 21 analysts recommending between $3.25 and $3.03.
According to 15 analysts, the current quarter’s revenue is expected to be $7.37B. It ranges from a high estimate of $7.74B to a low estimate of $6.58B. As of the current estimate, Mondelez International Inc.’s year-ago sales were $7.18B, an estimated increase of 2.60% from the year-ago figure. For the next quarter, 15 analysts are estimating revenue of $7.96B, an increase of 4.00% over than the figure of $2.60% in the same quarter last year. There is a high estimate of $8.27B for the next quarter, whereas the lowest estimate is $7.04B.
A total of 17 analysts have provided revenue estimates for MDLZ’s current fiscal year. The highest revenue estimate was $30.64B, while the lowest revenue estimate was $29.49B, resulting in an average revenue estimate of $30.3B. In the same quarter a year ago, actual revenue was $28.72B, up 5.50% from the average estimate. Based on 19 analysts’ estimates, the company’s revenue will be $31.59B in the next fiscal year. The high estimate is $32.49B and the low estimate is $30.73B. The average revenue growth estimate for next year is up 4.30% from the average revenue estimate for this year.